Corbus Pharmaceuticals Holdings Inc (CRBP)
45.02
+3.64
(+8.80%)
USD |
NASDAQ |
May 24, 16:00
44.98
-0.04
(-0.09%)
After-Hours: 20:00
Corbus Pharmaceuticals Holdings Total Assets (Quarterly): 125.74M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 125.74M |
December 31, 2023 | 28.27M |
September 30, 2023 | 36.28M |
June 30, 2023 | 43.72M |
March 31, 2023 | 51.65M |
December 31, 2022 | 66.31M |
September 30, 2022 | 73.83M |
June 30, 2022 | 82.07M |
March 31, 2022 | 95.68M |
December 31, 2021 | 107.73M |
September 30, 2021 | 119.57M |
June 30, 2021 | 120.61M |
March 31, 2021 | 140.14M |
December 31, 2020 | 102.29M |
September 30, 2020 | 95.84M |
June 30, 2020 | 98.12M |
March 31, 2020 | 65.20M |
December 31, 2019 | 49.14M |
September 30, 2019 | 68.13M |
June 30, 2019 | 84.12M |
Date | Value |
---|---|
March 31, 2019 | 101.39M |
December 31, 2018 | 46.99M |
September 30, 2018 | 61.18M |
June 30, 2018 | 70.29M |
March 31, 2018 | 77.14M |
December 31, 2017 | 66.98M |
September 30, 2017 | 38.42M |
June 30, 2017 | 44.56M |
March 31, 2017 | 50.61M |
December 31, 2016 | 17.89M |
September 30, 2016 | 19.76M |
June 30, 2016 | 22.63M |
March 31, 2016 | 10.50M |
December 31, 2015 | 12.88M |
September 30, 2015 | 13.33M |
June 30, 2015 | 9.565M |
March 31, 2015 | 5.246M |
December 31, 2014 | 6.601M |
September 30, 2014 | 7.630M |
December 31, 2013 | 0.3055M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
28.27M
Minimum
Dec 2023
140.14M
Maximum
Mar 2021
82.72M
Average
83.09M
Median
Total Assets (Quarterly) Benchmarks
AIM ImmunoTech Inc | 16.19M |
Perspective Therapeutics Inc | 278.29M |
Protalix BioTherapeutics Inc | 89.82M |
Electromed Inc | 48.90M |
Armata Pharmaceuticals Inc | 120.36M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 28.78M |
Shareholders Equity (Quarterly) | 96.97M |